Bluejay Diagnostics
BJDX
5 hedge funds and large institutions have $109K invested in Bluejay Diagnostics in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
25% less capital invested
Capital invested by funds: $146K → $109K (-$37K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$65K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$21.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$12K |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $28.5K | +$65K | +3 | New |
|
2
Renaissance Technologies
New York
| $25K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $10K | – | – | – |
|
|
SM
4
Sabby Management
Miami Beach,
Florida
| $9.91K | – | – | – |
|
|
TSS
5
Two Sigma Securities
New York
| $6.78K | +$21.7K | +1 | New |
|
6
Vanguard Group
Malvern,
Pennsylvania
| $6.04K | – | – | – |
|
|
SG
7
StoneX Group
New York
| $5.7K | – | – | – |
|
8
Citadel Advisors
Miami,
Florida
| $4.76K | – | – | – |
|
9
Northern Trust
Chicago,
Illinois
| $4.44K | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $4K | – | – | – |
|
11
UBS Group
Zurich,
Switzerland
| $3.82K | – | – | – |
|
12
Wells Fargo
San Francisco,
California
| $26 | – | – | – |
|
13
Bank of America
Charlotte,
North Carolina
| $4 | – | – | – |
|
|
14
Millennium Management
New York
| – | -$12K | – | – |
|
|
15
Verition Fund Management
Greenwich,
Connecticut
| – | -$12K | – | – |
|
BJDX Hedge Fund Activity: Q4 2022 in Review
5 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q4 2022, worth a combined $109K — down 25% from $146K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BJDX positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $65K. The largest seller was Millennium Management, cutting an estimated $12K.
- 5 institutional investors held Bluejay Diagnostics (BJDX) as of Q4 2022, up from 3 in Q3 2022.
- Funds reported $109K of Bluejay Diagnostics stock for Q4 2022, down 25% quarter-over-quarter.
- 2 funds opened new Bluejay Diagnostics positions in Q4 2022 and 0 closed out, a net change of +2 holders.
- The largest Bluejay Diagnostics buyer in Q4 2022 was Susquehanna International Group, an estimated $65K added.
- The largest Bluejay Diagnostics seller in Q4 2022 was Millennium Management, an estimated $12K sold.
Based on aggregated 13F filings for Q4 2022.